416 filings
S-4/A
ONC
BeiGene, Ltd.
21 Jan 25
Registration of securities issued in business combination transactions (amended)
4:06pm
8-K
ONC
BeiGene, Ltd.
13 Jan 25
Regulation FD Disclosure
5:02pm
10-K/A
2023 FY
ONC
BeiGene, Ltd.
8 Jan 25
Annual report (amended)
6:02am
8-K
ONC
BeiGene, Ltd.
23 Dec 24
Other Events
6:05am
8-K
ONC
BeiGene, Ltd.
10 Dec 24
Entry into a Material Definitive Agreement
6:02am
8-K
e1x5fwef
19 Nov 24
Other Events
6:03am
8-K
nrifw2fxzj
14 Nov 24
Other Events
6:05am
8-K
0uzxsi nbv98
12 Nov 24
BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates
6:03am
8-K
6ih5t7g
28 Oct 24
Other Events
6:05am
8-K
dty3 mysvdmgte2qf
30 Sep 24
Other Events
6:02am
8-K
3e4ohcwe9dy63
26 Sep 24
Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
6:12am
8-K
ycmvmw9hdtht7vd6x
29 Aug 24
Results of Operations and Financial Condition
7:29am
S-4
73qyzlroexb
7 Aug 24
Registration of securities issued in business combination transactions
7:32am
8-K
qvc1 fw5of5
7 Aug 24
BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
6:04am
8-K
of0ckv7tstr a8gt3y
18 Jul 24
BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer
6:40am
S-8
ffdsmas8n6tv qxb4
5 Jun 24
Registration of securities for employees
5:23pm
8-K
socbi4793
5 Jun 24
Departure of Directors or Certain Officers
4:35pm